Check-Cap Ltd.

NASDAQ:CHEK

1.55 (USD) • At close December 24, 2024
Bedrijfsnaam Check-Cap Ltd.
Symbool CHEK
Munteenheid USD
Prijs 1.55
Beurswaarde 9,068,058
Dividendpercentage 0%
52-weken bereik 0.56 - 3.45
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Alex Ovadia
Website https://www.check-cap.com

An error occurred while fetching data.

Over Check-Cap Ltd.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for

Vergelijkbare Aandelen

Delcath Systems, Inc. logo

Delcath Systems, Inc.

DCTH

11.34 USD

Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc.

CABA

2.34 USD

Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp.

TNXP

0.385 USD

Immunome, Inc. logo

Immunome, Inc.

IMNM

11.02 USD

X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.

XFOR

0.58 USD

Protara Therapeutics, Inc. logo

Protara Therapeutics, Inc.

TARA

5.17 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)